Darwin Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.05K Sell
90
-151
-63% -$12.2K ﹤0.01% 412
2026
Q1
$21K Buy
241
+51
+27% +$4.89K 0.01% 302
2025
Q4
$18.3K Sell
190
-98
-34% -$9.52K 0.01% 316
2025
Q3
$27.5K Buy
288
+101
+54% +$9.29K 0.01% 265
2025
Q2
$16.4K Sell
187
-102
-35% -$8.65K 0.01% 306
2025
Q1
$23.1K Hold
289
0.01% 288
2024
Q4
$23.1K Sell
289
-11
-4% -$952 0.01% 288
2024
Q3
$27K Buy
+300
New +$25.2K 0.01% 286
2020
Q2
Sell
-904
Closed -$81K 503
2020
Q1
$81K Sell
904
-1,593
-64% -$169K 0.03% 193
2019
Q4
$283K Buy
2,497
+244
+11% +$26.8K 0.08% 133
2019
Q3
$245K Sell
2,253
-485
-18% -$50.6K 0.07% 134
2019
Q2
$267K Buy
2,738
+489
+22% +$44.6K 0.08% 131
2019
Q1
$205K Buy
+2,249
New +$201K 0.07% 142

Other funds holding MDT

Darwin Wealth Management's MDT Position: Q2 2026 in Review

Darwin Wealth Management reduced its Medtronic (MDT) stake by 63% in Q2 2026, selling an estimated $12.2K and leaving 90 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Darwin Wealth Management first reported a position in MDT in Q1 2019 and has held it in 13 quarters since. The position peaked at $283K in Q4 2019. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Darwin Wealth Management held 90 shares of Medtronic worth $7.05K as of Q2 2026.
  • Darwin Wealth Management sold 151 Medtronic shares in Q2 2026, an estimated $12.2K.
  • Medtronic made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #412 holding.
  • Darwin Wealth Management first reported a position in Medtronic in Q1 2019 and has held it in 13 quarters since.
  • Darwin Wealth Management's Medtronic position peaked at $283K in Q4 2019.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.